Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 186, 171-174
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A Survey of ASAM Members’ Knowledge, Attitudes, and Practices in Urine Drug TestingJournal of Addiction Medicine, 2015
- Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid UseJournal of Psychoactive Drugs, 2015
- Buprenorphine Diversion and Misuse in Outpatient PracticeJournal of Addiction Medicine, 2014
- Deception for Drugs: Self-Reported "Doctor Shopping" Among Young AdultsThe Journal of the American Board of Family Medicine, 2014
- Differential diagnosis for a stable patient maintained on buprenorphine who gives a urine toxicology screen negative for buprenorphineThe American Journal on Addictions, 2014
- Just Say “I Don't”: Lack of Concordance Between Teen Report and Biological Measures of Drug UsePediatrics, 2010
- Urinary Buprenorphine Concentrations in Patients Treated with Suboxone(R); as Determined by Liquid Chromatography-Mass Spectrometry and CEDIA ImmunoassayJournal of Analytical Toxicology, 2008
- Mode of questionnaire administration can have serious effects on data qualityJournal of Public Health, 2005
- Lying in everyday life.Journal of Personality and Social Psychology, 1996
- Self-Reported Drug Use Data: What Do They Reveal?The American Journal of Drug and Alcohol Abuse, 1993